Home/Filings/4/0001104659-20-071413
4//SEC Filing

Bergmann Anthony 4

Accession 0001104659-20-071413

CIK 0001133869other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:33 PM ET

Size

6.2 KB

Accession

0001104659-20-071413

Insider Transaction Report

Form 4
Period: 2020-06-05
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-05+120,003120,003 total
    Exercise: $1.39Exp: 2030-06-05Common Stock (120,003 underlying)
Footnotes (1)
  • [F1]The shares vest 1/48th of the first day of each month, commencing March 1, 2020, until the stock option becomes fully vested and exercisable. The following stock option grant was approved by the Board on February 12, 2020 under the 2020 Plan, contingent upon stockholder approval of the 2020 Plan, which was obtained on June 5, 2020. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001593087

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:33 PM ET
Size
6.2 KB